Trump just signed a new law to help measure the effectiveness of government programs. That’s good, but not good enough.
The government had been shut for more than three weeks when President Donald Trump decided to strike a blow for sensible policymaking. (Go figure.) On Jan. 14, he signed the Foundations for Evidence-Based Policymaking Act, legislation that aims to improve data analysis and program evaluation. Read More
Government spending and tax cuts kept the financial crisis from getting worse. They also taught fiscal-policy lessons the U.S. might need soon.
t’s been a decade since Congress approved a huge emergency package of spending projects, payments to individuals and tax cuts to stimulate a U.S. economy staggered by the 2008 recession. We know now that it worked, limiting the damage caused by the downturn and vindicating the idea that government spending during periods of economic weakness saves jobs and speeds recovery. We also know that it could have worked better. Read More
The drug and medical program gives insurance companies an incentive to take into account the effects of prescription drugs on the cost of care.
Recent data show that drug overdose deaths in the U.S. were 10 percent higher in 2017 than 2016, with an almost 50 percent increase in those related to synthetic opioids. A new research paper points to a glimmer of hope in this otherwise bleak story: Medicare Advantage insurance companies seem to be doing a surprisingly good job at mitigating opioid abuse. Read More